一个新的左心房附属体隔离策略,用于持续性心房,需要重复切除
Patricia Tung1, Juliana Pérez-Pinzón2, Daniel Villarreal Garcia1
1Harvard Thorndike Electrophysiology Institute, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Heart rhythm
|December 21, 2025
概括
使用前和后线与马歇尔静脉乙醇切除的左心房附属体隔离 (LAAI) 对持久性心房动 (AF) 患者是可行的. 这种方法显示持久的LAAI和减少心律失常的复发,没有报告的中风.
科学领域:
- 心脏病学 心脏病学
- 电力生理学 电力生理学
- 医疗器械 医疗器械
背景情况:
- 左心房附属体 (LAA) 是心房动 (AF) 触发的关键来源,在经历重复切除的患者中.
- 以前的左心房附属体隔离 (LAAI) 方法的成功和风险各不相同.
研究的目的:
- 为了评估LAAI的可行性和有效性,使用前额叶线 (AML) 和后额叶线 (PML) 加上马歇尔静脉乙醇切除 (VOM).
- 评估LAAI的持久性及其对持续性AF患者心律失常复发的影响.
主要方法:
- 对23名患者进行前性研究,这些患者因持续性AF而经历了重复切除.
- 使用AML和PML进行的LAAI,有或没有VOM.
- 系统地重新绘制LAAI耐久性评估和Kaplan-Meier分析无心律失常生存率.
主要成果:
- 所有患者都获得了急性LAAI; 61%的患者获得了持久的LAAI.
- 一年后,心律不整的复发率为61%,主要是心房低心率 (AT).
- 没有观察到急性血栓,中风或TIA.
结论:
- 通过VOM的线性AML和PML方法进行LAAI是可行的和可重复的.
- 这种技术导致自我限定的心律失常复发率较低.
- 该方法证明了安全性和潜在的改善结果在持续的AF.
相关概念视频
Cardiac Catheterization III: Left Heart Catheterization
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Pericarditis III: Medical Management
The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...


